Cargando…

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

The objective of this work is to analyze the survival of infliximab, etanercept and adalimumab in patients who have switched among tumor necrosis factor (TNF) antagonists for the treatment of chronic arthritis. BIOBADASER is a national registry of patients with different forms of chronic arthritis w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomez-Reino, Juan J, Carmona, Loreto
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526564/ https://www.ncbi.nlm.nih.gov/pubmed/16507128 http://dx.doi.org/10.1186/ar1881

Ejemplares similares

Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER
por: Carmona, Loreto, et al.
Publicado: (2006)

DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
por: Navarro-Sarabia, Federico, et al.
Publicado: (2009)

Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis
por: Maneiro, Jose Ramon, et al.
Publicado: (2015)

Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases
por: Sauzullo, Ilaria, et al.
Publicado: (2018)

Switching from a first to a second tumour necrosis factor (TNF) alpha antagonist in patients with juvenile idiopathic arthritis
por: Schmeling, H, et al.
Publicado: (2008)

Effect of TNF antagonists on the productivity of daily work of patients with rheumatoid arthritis
por: Furuya, Hidekazu, et al.
Publicado: (2013)

Treating psoriatic arthritis: how effective are TNF antagonists?
por: Gottlieb, Alice B, et al.
Publicado: (2004)

MicroRNA-488 and -920 regulate the production of proinflammatory cytokines in acute gouty arthritis
por: Zhou, Weidong, et al.
Publicado: (2017)

Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
por: Burstein, Aaron H, et al.
Publicado: (2014)

Séminaire Bourbaki : exposés 471–488
por: Collective
Publicado: (1977)

PReS-FINAL-2168: Comparison of safety and retention rate of TNF antagonist therapy in juvenile-onset and adult-onset ankylosing spondylitis: data from the spanish registry biobadaser 2.0
por: Sifuentes Giraldo, WA, et al.
Publicado: (2013)

Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis
por: Lim, Heejin, et al.
Publicado: (2018)

Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis
por: Cui, Xiaofang, et al.
Publicado: (2018)

High Sodium Intake Is Associated With Self-Reported Rheumatoid Arthritis: A Cross Sectional and Case Control Analysis Within the SUN Cohort
por: Salgado, Eva, et al.
Publicado: (2015)

Descriptive Study of a Cohort of 488 Patients with Inherited Retinal Dystrophies
por: Coco-Martin, Rosa M, et al.
Publicado: (2021)

Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
por: Germano, Valentina, et al.
Publicado: (2014)

AG488 as a therapy against gliomas
por: Ziegler, Jadith, et al.
Publicado: (2017)

SUN-488 Opioid Induced Pituitary Dysfunction
por: Bedoya, Pablo, et al.
Publicado: (2019)

Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
por: Hernández-Cruz, Blanca, et al.
Publicado: (2016)

488 Treatment Outcomes in Patients with Extended-Spectrum Beta-lactamase Producing Organisms
por: Lee, Eunbae, et al.
Publicado: (2014)

Plasma leptin and neuropeptide Y concentrations in patients with rheumatoid arthritis treated with infliximab, a TNF-α antagonist
por: Kopec-Medrek, Magdalena, et al.
Publicado: (2011)

The Effect of TNF-α on CHD and the Relationship between TNF-α Antagonist and CHD in Rheumatoid Arthritis: A Systematic Review
por: Qian, Yezhou, et al.
Publicado: (2022)

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study
por: Emery, P, et al.
Publicado: (2015)

Comparative Persistence of the TNF Antagonists in Rheumatoid Arthritis – A Population-Based Cohort Study
por: Fisher, Anat, et al.
Publicado: (2014)

Effective use of TNF antagonists
por: Yocum, David
Publicado: (2004)

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists
por: Finckh, Axel, et al.
Publicado: (2012)

Therapeutic Vaccination with TNF-Kinoid in TNF Antagonist-Resistant Rheumatoid Arthritis: A Phase II Randomized, Controlled Clinical Trial
por: Durez, Patrick, et al.
Publicado: (2014)

488 The Effect of Specific Immunotherapy on the Clinical Response in Patients with Grass-pollen Induced Rhinoconjunctivitis
por: Arsovski, Zoran, et al.
Publicado: (2012)

Physics Run Analysis No. 3 - 1974, Run 488 to 504 - Period 5, 3rd to 26th July, 1974
por: Verbeeck, T
Publicado: (1974)

MON-488 Technologies of Diffuse Optics in the Diagnosis of Thyroid Cancer
por: Velazquez, Gloria Beatriz Aranda, et al.
Publicado: (2020)

Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort
por: González-Alvaro, Isidoro, et al.
Publicado: (2008)

Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study
por: Suarez-Gestal, Marian, et al.
Publicado: (2010)

Target switch of centipede toxins for antagonistic switch
por: Yang, Shilong, et al.
Publicado: (2020)

Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?
por: Manica, Santiago Rodrigues, et al.
Publicado: (2020)

Outcome of patients with sarcoidosis refractory to TNF antagonists: a case series
por: Thery-Casari, Clémence, et al.
Publicado: (2018)

Could TNF-antagonists be a novel treatment strategy for BPH patients?
por: Vickman, Renee E., et al.
Publicado: (2022)

TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collagen-induced arthritis mouse models
por: Wu, Jiao, et al.
Publicado: (2022)

TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients
por: Al-Rayes, Hannan, et al.
Publicado: (2011)

The 'Switch’ study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug
por: Navarro Coy, Nuria C, et al.
Publicado: (2014)

Apprentissage et utilisation du BUS IEEE 488/CEI 625
por: Vey, Jean Jacques
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_j8t6p63h6iku4jist07qva6p8l